Begoña
López Salazar
Profesional Investigadora
Publicaciones (135) Publicaciones de Begoña López Salazar
2024
-
Circulating biomarkers of myocardial remodelling: current developments and clinical applications
Heart, Vol. 110, Núm. 19, pp. 1157-1163
-
Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management
Hypertension, Vol. 81, Núm. 2, pp. 218-228
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12
-
ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload
Communications Biology, Vol. 5, Núm. 1
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331
-
Heart failure in chronic kidney disease: The emerging role of myocardial fibrosis
Nephrology Dialysis Transplantation, Vol. 37, Núm. 5, pp. 817-824
2021
-
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498
-
Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
JACC: Basic to Translational Science, Vol. 6, Núm. 1, pp. 12-21
2020
-
Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Scientific Reports, (2017), 7, 1, (40696), 10.1038/srep40696)
Scientific Reports
-
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
Nefrologia, Vol. 40, Núm. 3, pp. 223-236
-
Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease
Journal of hypertension, Vol. 38, Núm. 10, pp. 2036-2042
-
Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 835-843
-
Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?
Journal of Clinical Medicine, Vol. 9, Núm. 2
-
H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts
Clinical Epigenetics, Vol. 12, Núm. 1
-
Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
Open Heart, Vol. 7, Núm. 1
-
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
Circulation, Vol. 141, Núm. 9, pp. 751-767
-
Reprint of “The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking”
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1867, Núm. 3
-
The Myocardium in Aortic Stenosis Revisited: More Complex Than Just Myocytes and Interstitial Diffuse Fibrosis
JACC: Cardiovascular Imaging
2019
-
Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study
Journal of Cardiovascular Electrophysiology, Vol. 30, Núm. 8, pp. 1231-1240
-
CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation: Mechanistic insights and clinical implications
Hypertension, Vol. 73, Núm. 3, pp. 602-611